Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Description
CONCLUSION: Patients on treatment with TNFα inhibitors have better humoral response compared to the other b/tsDMARDs. However, when associated with methotrexate the seroprevalence decreases significantly.
